Skip to main content
Aurobindo bids to purchase Novartis' generics drug dermatology business
5/7/2018

Hyderabad, India-based Aurobindo Pharma submitted an initial $1.6 billion bid to purchase Novartis' dermatology generics drug business, which includes dermatology brands plus the company's production facilities and other infrastructure.

Full Story: